BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18668513)

  • 1. Prognostic factors in children with Hodgkin disease.
    Celkan T; Yildiz I
    Pediatr Blood Cancer; 2008 Nov; 51(5):712; author reply 712-3. PubMed ID: 18668513
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of recurrences of lymphogranulomatosis].
    Kovryzhkina TA
    Med Radiol (Mosk); 1984 Jan; 29(1):35-9. PubMed ID: 6546406
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined therapy of lymphogranulomatosis].
    Vorob'ev AI; Fokina NT; Brilliant MD; Fil'kova EM
    Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):3-7. PubMed ID: 6895412
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease.
    Tubiana M; Mathé G
    Ser Haematol; 1973; 6(2):202-43. PubMed ID: 4206180
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomy.
    Hagemeister FB; Fuller LM; Sullivan JA; North L; Velasquez W; Conrad FG; McLaughlin P; Butler JJ; Shullenberger CC
    Radiology; 1981 Dec; 141(3):783-9. PubMed ID: 6895415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy of Hodgkin's disease].
    Gallmeier WM; Bruntsch U
    Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
    [No Abstract]   [Full Text] [Related]  

  • 7. Early-stage Hodgkin's disease: a choice of treatments or a treatment of choice?
    Hoppe RT
    J Clin Oncol; 1991 Jun; 9(6):897-901. PubMed ID: 2033425
    [No Abstract]   [Full Text] [Related]  

  • 8. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
    Sagar TG; Chandra A; Raman SG
    Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
    [No Abstract]   [Full Text] [Related]  

  • 9. Hodgkin's disease in adults: the challenge.
    Lister TA
    Postgrad Med J; 1985 Feb; 61(712):103-7. PubMed ID: 3838586
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation and treatment of Hodgkin's disease in the 70's.
    Einhorn LH
    Conn Med; 1975 Nov; 39(11):694-8. PubMed ID: 1102248
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of Hodgkin disease with modified MOPP].
    Amiel JL; Spielmann M; Kerbrat P; Droz JP; Tursz T; Ben Ayed F
    Schweiz Rundsch Med Prax; 1983 Feb; 72(6):190-3. PubMed ID: 6687638
    [No Abstract]   [Full Text] [Related]  

  • 12. International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
    Kaplan HS; Rosenberg SA
    Natl Cancer Inst Monogr; 1973 May; 36():363-71. PubMed ID: 4582994
    [No Abstract]   [Full Text] [Related]  

  • 13. Updated Hodgkin's disease. C. Advanced disease and special problems. Combined chemotherapy-radiotherapy program.
    Fuller LM; Gamble JF
    JAMA; 1973 Jan; 223(2):168-9. PubMed ID: 4739457
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of lymphogranulomatosis].
    Baĭsogolov GD
    Med Radiol (Mosk); 1982 Sep; 27(9):83-9. PubMed ID: 6897278
    [No Abstract]   [Full Text] [Related]  

  • 15. Hodgkin's disease in childhood.
    Young RC; DeVita VT; Johnson RE
    Blood; 1973 Aug; 42(2):163-74. PubMed ID: 4793108
    [No Abstract]   [Full Text] [Related]  

  • 16. Stage I-II Hodgkin's disease: current therapeutic options and recommendations.
    Hoppe RT
    Blood; 1983 Jul; 62(1):32-6. PubMed ID: 6688032
    [No Abstract]   [Full Text] [Related]  

  • 17. Hodgkin's disease.
    Gassmann W; Schmitz N; Kayser W; Löffler H
    Cancer Treat Rev; 1984 Dec; 11(4):311-4. PubMed ID: 6549501
    [No Abstract]   [Full Text] [Related]  

  • 18. Will doxorubicin-containing regimens replace MOPP and its variants?
    Canellos GP; Rosenberg W
    Leukemia; 1991; 5 Suppl 1():50-2. PubMed ID: 1890866
    [No Abstract]   [Full Text] [Related]  

  • 19. [Remission with antineoplastic agents?].
    Ersbøll J
    Ugeskr Laeger; 1989 Jul; 151(29):1885-6. PubMed ID: 2773106
    [No Abstract]   [Full Text] [Related]  

  • 20. Hodgkin's disease in a patient after treatment for angioimmunoblastic lymphadenopathy.
    Melato M; Falconieri G; Giammarini Barsanti A; Mottola A
    Haematologica; 1983; 68(5):675-9. PubMed ID: 6416946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.